Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane C Weeks

Showing results (31-40 of 166) with videos related to

Pageof 17
Sort By:
Journal of the American College of Surgeons|February 21, 2009
Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancerMonika K Krzyzanowska, Meredith M Regan, Mark Powell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 26, 2014
Physicians' attitudes about multiplex tumor genomic testingStacy W Gray, Katherine Hicks-Courant, Angel Cronin, et al.
BMJ (Clinical Research Ed.)|March 6, 2014
Associations between palliative chemotherapy and adult cancer patients' end of life care and place of death: prospective cohort studyAlexi A Wright, Baohui Zhang, Nancy L Keating, et al.
International Journal of Radiation Oncology, Biology, Physics|October 13, 2012
Use of stereotactic radiosurgery for brain metastases from non-small cell lung cancer in the United StatesLia M Halasz, Jane C Weeks, Bridget A Neville, et al.
Journal of the National Cancer Institute|November 1, 2011
Re: personalized medicine and cancer supportive care: appropriate use of colony-stimulating factor support of chemotherapyArnold L Potosky, Jennifer L Malin, Benjamin Kim, et al.
Cancer|May 17, 2006
The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer: a decision analysisRinaa S Punglia, Karen M Kuntz, Eric P Winer, et al.
Breast Cancer Research and Treatment|September 27, 2005
Adjuvant ovarian suppression versus chemotherapy for premenopausal, hormone-responsive breast cancer: quality of life and efficacy tradeoffsElena B Elkin, Milton C Weinstein, Karen M Kuntz, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 12, 2006
The effect of age, race and gender on preference scores for hypothetical health statesEve Wittenberg, Elkan Halpern, Nomia Divi, et al.
BMJ (Clinical Research Ed.)|March 4, 2010
Impact of interval from breast conserving surgery to radiotherapy on local recurrence in older women with breast cancer: retrospective cohort analysisRinaa S Punglia, Akiko M Saito, Bridget A Neville, et al.
Cancer|November 8, 2012
Impact of oncology-related direct-to-consumer advertising: association with appropriate and inappropriate prescriptionsGregory A Abel, Kun Chen, Nathan Taback, et al.
Pageof 17

Showing results (31-40 of 166) with videos related to

Sort By:
Pageof 17
Journal of the American College of Surgeons|February 21, 2009
Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancerMonika K Krzyzanowska, Meredith M Regan, Mark Powell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 26, 2014
Physicians' attitudes about multiplex tumor genomic testingStacy W Gray, Katherine Hicks-Courant, Angel Cronin, et al.
BMJ (Clinical Research Ed.)|March 6, 2014
Associations between palliative chemotherapy and adult cancer patients' end of life care and place of death: prospective cohort studyAlexi A Wright, Baohui Zhang, Nancy L Keating, et al.
International Journal of Radiation Oncology, Biology, Physics|October 13, 2012
Use of stereotactic radiosurgery for brain metastases from non-small cell lung cancer in the United StatesLia M Halasz, Jane C Weeks, Bridget A Neville, et al.
Journal of the National Cancer Institute|November 1, 2011
Re: personalized medicine and cancer supportive care: appropriate use of colony-stimulating factor support of chemotherapyArnold L Potosky, Jennifer L Malin, Benjamin Kim, et al.
Cancer|May 17, 2006
The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer: a decision analysisRinaa S Punglia, Karen M Kuntz, Eric P Winer, et al.
Breast Cancer Research and Treatment|September 27, 2005
Adjuvant ovarian suppression versus chemotherapy for premenopausal, hormone-responsive breast cancer: quality of life and efficacy tradeoffsElena B Elkin, Milton C Weinstein, Karen M Kuntz, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 12, 2006
The effect of age, race and gender on preference scores for hypothetical health statesEve Wittenberg, Elkan Halpern, Nomia Divi, et al.
BMJ (Clinical Research Ed.)|March 4, 2010
Impact of interval from breast conserving surgery to radiotherapy on local recurrence in older women with breast cancer: retrospective cohort analysisRinaa S Punglia, Akiko M Saito, Bridget A Neville, et al.
Cancer|November 8, 2012
Impact of oncology-related direct-to-consumer advertising: association with appropriate and inappropriate prescriptionsGregory A Abel, Kun Chen, Nathan Taback, et al.
Pageof 17